Journal profile
Novartis Foundation symposium
ISSN 1528-2511 · eISSN 1935-4657 · Irregular
Novartis Foundation symposium: subscription journal; review about 1 month (community reports); community-reported acceptance: about 95%; 0 articles in 2025.
Scope
Aims, scope and focus
By OpenAlex counts of its recent articles, Novartis Foundation symposium's largest topics are Neuroscience and Neuropharmacology Research, Developmental Biology and Gene Regulation and T-cell and B-cell Immunology, together about 22.5% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
The Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results.
From the journal's Aims & Scope
Main research topics OpenAlex counts of recent articles; shares are approximate
- Neuroscience and Neuropharmacology ResearchNeuroscience8.2%
- Developmental Biology and Gene RegulationBiochemistry, Genetics and Molecular Biology7.2%
- T-cell and B-cell ImmunologyImmunology and Microbiology7.1%
- Adrenal Hormones and DisordersMedicine4.7%
- Ion channel regulation and functionBiochemistry, Genetics and Molecular Biology4.7%
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology4.6%
- Ion Transport and Channel RegulationBiochemistry, Genetics and Molecular Biology4.5%
- Growth Hormone and Insulin-like Growth FactorsMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 123OpenAlex ·
- i10-index
- 3,503OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 9,093 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 640 |
| 2025 | 0 | 0 | 1,432 |
| 2024 | 0 | 0 | 1,942 |
| 2023 | 0 | 0 | 2,005 |
| 2022 | 0 | 0 | 2,036 |
| 2021 | 0 | 0 | 2,315 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 95%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Frequency
- Irregular
- ISSN
- 1528-2511
- Electronic ISSN
- 1935-4657
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Novartis Foundation symposium
How long does peer review take at Novartis Foundation symposium?
Authors report an average review time of about 1 month; the community-reported acceptance is “about 95%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Is Novartis Foundation symposium open access, and what is the APC?
Novartis Foundation symposium is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .